Ignite Creation Date:
2024-05-06 @ 2:34 AM
Last Modification Date:
2024-10-26 @ 11:20 AM
Study NCT ID:
NCT02076685
Status:
UNKNOWN
Last Update Posted:
2014-03-17
First Post:
2012-11-16
Brief Title:
NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
The Application of the N-acetyltransferase 2 NAT2 Genotyping in Re-challenge Protocol of Isoniazid INH Titration in Patients With Anti-TB Medications-induced Hepatitis
Status:
UNKNOWN
Status Verified Date:
2014-03
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To improve the treatment outcome in patients with tuberculosis and integrate the pharmacogenetics into clinical practice the information of NAT2 genotyping was used in re-challenge protocol for isoniazid INH titration in patients with anti-tuberculosis medication-induced hepatitis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None